Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

Lexaria Bioscience (LEXX) provides the following glucagon-like peptide-1 industry update. It is no surprise that Novo Nordisk’s ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...

Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days, a 25% ...

Lexaria's strategy is to continue developing and optimizing our wholly-owned DehydraTECH™ drug delivery platform for application in the GLP-1 space, positioning it as a 'must-have' technology for ...

If you had come across the abbreviation GLP-1 a few years ago, chances are you’d have had no idea what it stood for. Intro to Greek lyric poetry? Low-level Great Lakes precipitation? A member of the ...

With rising GLP-1 use for weight ... include the launch of life’sDHA ®, a pioneering omega-3 ingredient from Martek Biosciences, now DSM-Firmenich, which became a half a billion dollar revenue ...

For Thursday, Oct. 31, WGN’s Dina Bair has the latest on new medical information, including: Weight loss drugs are safe for use before surgery. A new study reveals patients may continue to take their ...

A new study reveals patients may continue to take their GLP-1 receptor agonists before undergoing ... Keeping sugar intake at minimum levels in early life lowers the risk for chronic diseases ...